Elenbecestat Uses, Dosage, Side Effects and more

Elenbecestat is under investigation in clinical trial NCT02956486 (A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease).

Attribute	Details
Trade Name	Elenbecestat
Generic	Elenbecestat
Elenbecestat Other Names	Elenbecestat
Type
Formula	C19H18F3N5O2S
Weight	Average: 437.44 Monoisotopic: 437.113330503
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph